Investors / Netherlands / BioGeneration Ventures
BioGeneration Ventures
Venture capital · Naarden, Netherlands · Europe
BioGeneration Ventures is a venture capital firm specialised in seed investment for innovative early-stage life sciences companies, and it generally acts as lead investor. It is the early-stage strategy of the Forbion-BGV platform of funds and is located with Forbion in Naarden, the Netherlands.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechseedtherapeuticsdrug developmenteurope
Your fit with BioGeneration Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBioGeneration Ventures lists 33 checked portfolio companies on its own site and is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 67% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 53% of its companies are based in Netherlands. It invests most often alongside Brabant Development Agency (BOM), Curie Capital and Epidarex.
Counts come from funding rounds that name BioGeneration Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not BioGeneration Ventures' whole history. Rounds on record name 3 companies; its own site lists 33. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 67% |
| Series B | 33% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 3 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 71th | 33 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 67th | 6% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 88th | 7 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Brabant Development Agency (BOM) | 5 |
| Curie Capital | 3 |
| Epidarex | 3 |
| Inkef | 3 |
| InnovationQuarter | 3 |
| Kurma Partners | 3 |
| Novartis Venture Fund | 3 |
| Seroba Life Sciences | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers33100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Brabant Development Agency (BOM)
Compare BioGeneration Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with BioGeneration Ventures| Date | Company | Stage |
|---|---|---|
| 6 Oct 2026 | Series A Led | |
| 5 Aug 2026 | Series B |
Round details for BioGeneration Ventures
Amounts, full round histories and every co-investor in BioGeneration Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
33 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Amgen operates in the biotechnology industry, conducting research and development, manufacturing, and distributing various therapies and products. | Healthcare & Biotech | Portfolio page | ||
| Artica Therapeutics is developing novel therapies for patients suffering from severe autoimmune and inflammatory disorders | Healthcare & Biotech | Portfolio page | ||
| Avidicure develops antibodies for patients with oncology and autoimmune diseases | Healthcare & Biotech | Portfolio page | ||
| Azafaros develops treatments for rare neurological diseases, including lysosomal storage disorders. | Healthcare & Biotech | Portfolio page | ||
| Brandaris Therapeutics is a biotech company developing drug candidates for the treatment of neuropsychiatric disorders. | Healthcare & Biotech | Portfolio page | ||
| Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases | Healthcare & Biotech | Portfolio page | ||
| CatalYm is developing a safe and efficacious immune therapy for solid tumors. | Healthcare & Biotech | Portfolio page | ||
| Citryll develops therapies to treat immune-mediated inflammatory diseases by targeting Extracellular Traps (ETs) | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Confo Therapeutics is a clinical-stage company committed to identifying and accelerating novel medicines for metabolic and endocrine diseases. | Healthcare & Biotech | Portfolio page | ||
| Epsilogen is a company that discovers and develops immunoglobulin IgE, IgA and IgG-based therapeutics for the treatment of cancer | Healthcare & Biotech | Portfolio page | ||
| Fibrocor Therapeutics is developing potential first-in-class therapies for kidney disease, guided by insights from human kidney tissue. | Healthcare & Biotech | Portfolio page | ||
| FundaMental Pharma is a neuroscience company developing novel dual-acting NMDA receptor modulators for treatment-resistant depression | Healthcare & Biotech | Portfolio page | ||
| Genase Therapeutics develops metabolism inhibitors for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| Kivu Bioscience develops next-generation antibody-drug conjugates to treat cancer. | Healthcare & Biotech | Portfolio page | ||
| MDxHealth develops and provides molecular diagnostic solutions for the earlier detection of aggressive prostate cancer and urologic diseases | Healthcare & Biotech | Portfolio page | ||
| Mellon Medical is developing an innovative suture tool, the Switch, which enables surgeons to set small-bite sutures more efficiently and quickly than traditional methods. | Healthcare & Biotech | Portfolio page | ||
| Mironid is a clinical stage biopharmaceutical company developing novel small-molecule therapeutics that directly target the central signalling mechanism that drives ADPKD. | Healthcare & Biotech | Aug 2026Series B | Page + round | |
| NewAmsterdam Pharma is advancing a new era of treatments for cardiovascular disease and other lipid-related conditions. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- biogenerationventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 5 Aug 2026
- Companies checked
- 33
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BioGeneration Ventures' profile as data
Pull BioGeneration Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/biogenerationventures.com
# also
GET /v1/firms/biogenerationventures.com/portfolio
GET /v1/firms/biogenerationventures.com/coinvestors
GET /v1/firms/biogenerationventures.com/news